[CLDX] YoY Quarter Result on 31-Mar-2013 [#Q1]

Stock
[CLDX] Celldex Therapeutics, Inc.
Announcement Date
03-May-2013
Financial Year
2013
Quarter
31-Mar-2013 [#Q1]
Profit Trend
QoQ- -3.12%
YoY- -28.23%
Quarter Report
CLDX's Result
CLDX's Financial Summary
View:
Show?
Quarter Result
31/03/16 31/03/15 31/03/14 31/03/13 31/03/12 31/03/11 31/03/10 CAGR
Revenue 1,303 486 416 2,414 2,433 2,516 3,713 -16.00%
PBT -34,673 -30,174 -29,903 -17,332 -13,083 -9,574 -6,245 33.03%
Tax -2,062 -1,614 -1,586 -379 -410 -268 -6,324 -17.02%
NP -34,673 -30,174 -29,903 -17,332 -13,516 -10,059 -6,582 31.87%
Tax Rate - - - - - - - -
Total Cost 35,976 30,660 30,319 19,746 15,949 12,575 10,295 23.16%
Ratio Analysis
31/03/16 31/03/15 31/03/14 31/03/13 31/03/12 31/03/11 31/03/10 CAGR
NP Margin -2,661.01 -6,208.64 -7,188.22 -717.98 -555.53 -399.80 -177.27 56.99%
Per Share
31/03/16 31/03/15 31/03/14 31/03/13 31/03/12 31/03/11 31/03/10 CAGR
EPS -5.27 -4.90 -5.02 -3.51 -4.04 -4.71 -3.11 9.17%
EPS Diluted -5.27 -4.90 -5.02 -3.51 -4.04 -4.71 -3.11 9.17%

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.